Skip to content
healthcare.dev

Fexofenadine HCL

NDC 11673-767, Fexofenadine HCL, tablet, from TARGET CORPORATION.

Product NDC
11673-767
Status
Listed
Labeler
TARGET CORPORATION
Dosage form
TABLET
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA211075
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/11673-767 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • FEXOFENADINE HYDROCHLORIDE180 mg/1

Pharmacologic classes

Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]

Package NDCNDC-11Package
11673-767-031167307670330 TABLET in 1 BOTTLE (11673-767-03)
11673-767-071167307670715 TABLET in 1 BLISTER PACK (11673-767-07)
11673-767-1511673076715150 TABLET in 1 BOTTLE (11673-767-15)
11673-767-341167307673470 TABLET in 1 BOTTLE (11673-767-34)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 11673-767 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/11673-767 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 11673-767. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.